Role of PLZF in melanoma progression

Oncogene

Volumn 23, Issue 26, 2004, Pages 4567-4576

  Felicetti, Federica ^a   Bottero, Lisabianca ^a   Felli, Nadia ^a   Mattia, Gianfranco ^a   Labbaye, Catherine ^a   Alvino, Ester ^b   Peschle, Cesare ^a   Colombo, Mario P ^c   Carè, Alessandra ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CNR   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

cDNA expression array; Homeobox gene; Melanoma; PLZF; Tumor progression

Indexed keywords

GELATINASE B; HOX PROTEIN; OSTEONECTIN; PROMYELOCYTIC LEUKEMIA PROTEIN; TYROSINASE RELATED PROTEIN 1; VITRONECTIN RECEPTOR; ZINC FINGER PROTEIN; DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; HOXB7 PROTEIN, HUMAN; HOXB7 PROTEIN, MOUSE; MEMBRANE PROTEIN; OXIDOREDUCTASE; PROTEIN; TRANSCRIPTION FACTOR; TYROSINASE RELATED PROTEIN; TYROSINASE-RELATED PROTEIN; TYRP1 PROTEIN, HUMAN; TYRP1 PROTEIN, MOUSE; ZBTB16 PROTEIN, HUMAN; ZBTB16 PROTEIN, MOUSE;

ARTICLE; CANCER GROWTH; CARCINOGENICITY; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; UPREGULATION; ANIMAL; CANCER INVASION; CARCINOGEN TESTING; CELL CULTURE; CELL DIVISION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; REFERENCE VALUE;

MUS MUSCULUS;

ANIMALS; CARCINOGENICITY TESTS; CELL DIVISION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; INTEGRIN ALPHAVBETA3; MATRIX METALLOPROTEINASE 9; MELANOCYTES; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; OSTEONECTIN; OXIDOREDUCTASES; PROMOTER REGIONS (GENETICS); PROTEINS; REFERENCE VALUES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 3042572346     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207597     Document Type: Article

References (40)

1. Abate-Shen C. (2002). Nat. Rev. Cancer, 2, 777-785.
2. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN. (1987). Cancer Res., 47, 3239-3245.
3. Alvino E, Marra G, Pagani E, Falcinelli S, Pepponi R, Perrera C, Haider R, Castiglia D, Ferranti G, Bonmassar E, Jiricny J, Zambruno G and D'Atri S. (2002). J. Invest. Dermatol., 118, 79-86.
4. Barna M, Hawe N, Niswander L and Pandolfi PP. (2000). Nat. Genet., 25, 166-172.
5. Barna M, Merghoub T, Costoya JA, Ruggero D, Branford M, Bergia A, Samori B and Pandolfi PP. (2002). Dev. Cell, 3, 499-510.
6. Boukerche H, Berthier-Vergnes O, Tabone E, Bailly M, Dore JF and McGregor JL. (1995). Br. J. Cancer, 72, 108-116.
7. Carè A, Felicetti F, Meccia E, Bottero L, Parenza M, Stoppacciaro A, Peschle C and Colombo MP. (2001). Cancer Res., 61, 6532-6539.
8. Carè A, Silvani A, Meccia E, Mattia G, Peschle C and Colombo MP. (1998). Oncogene, 16, 3285-3289.
9. Carè A, Silvani A, Meccia E, Mattia G, Stoppacciaro A, Parmiani G, Peschle C and Colombo MP. (1996). Mol. Cell. Biol., 16, 4842-4851.
10. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY, Waxman S and Zelent A. (1993). EMBO J., 12, 1161-1167.
11. Cohen T, Muller RM, Tomita Y and Shibahara S. (1990). Nucleic Acids Res., 18, 2807-2808.
12. Cook M, Gould A, Brand N, Davies J, Strutt P, Shaknovich R, Licht J, Waxman S, Chen Z, Gluecksohn-Waelsch S, Krumlauf R and Zelent A. (1995). Proc. Natl. Acad. Sci. USA, 92, 2249-2253.
13. Dhordain P, Albagli O, Honore N, Guidez F, Lantoine D, Schmid M, De The H, Zelent A and Koken MHM. (2000). Oncogene, 19, 6240-6250.
14. Dong S, Zhu J, Reid A, Strutt P, Guidez F, Zhong HJ, Wang ZY, Licht J, Waxman S, Chomienne C, Chen Z, Zelent A and Chen S-J. (1996). Proc. Natl. Acad. Sci. USA, 93, 3624-3629.
15. Dubrulle J and Pourquie O. (2002). Curr. Opin. Genet. Dev., 12, 519-523.
16. Fang D, Tsuji Y and Setaluri V. (2002). Nucleic Acids Res., 30, 3096-3106.
17. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A and Pandolfi PP. (1998). Nat. Genet., 18, 126-135.
18. Hoatlin ME, Zhi Y, Ball H, Silvey K, Melnick A, Stone S, Arai S, Hawe N, Owen G, Zelent A and Licht JD. (1999). Blood, 94, 3737-3747.
19. Hofmann UB, Westphal JR, Waas ET, Becker JC, Ruiter DJ and van Muijen GN. (2000). J. Invest. Dermatol., 115, 625-632.
20. Krug U, Ganser A and Koeffler HP. (2002). Oncogene, 21, 3475-3495.
21. Labbaye C, Quaranta MT, Pagliuca A, Militi S, Licht JD, Testa U and Peschle C. (2002). Oncogene, 21, 6669-6679.
22. Lacal PM, Failla CM, Pagani E, Odorisio T, Schietroma C, Falcinelli S, Zambruno G and D'Atri S. (2000). J. Invest. Dermatol., 115, 1000-1007.
23. Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, Mordoh J and Podhajcer OL. (1997). Nat. Med., 3, 171-176.
24. Li JY, English MA, Ball HJ, Yeyati PL, Waxman S and Licht JD. (1997). J. Biol. Chem., 272, 22447-22455.
25. Licht JD, Chomienne C, Goy A, Chen A, Scott AA, Head DR, Michaux JL, Wu Y, DeBlasio A, Miller Jr WH, Zelenetz AD, Willman CL, Chen Z, Chen S-J, Zelent A, Macintyre E, Veil A, Corets J, Kantarjian H and Waxman S. (1995). Blood, 85, 1083-1094.
26. Livak KL and Schmittgen TD. (2001). Methods, 25, 402-408.
27. McPherson LA, Baichwal VR and Weigel RJ. (1997). Proc. Natl. Acad. Sci. USA, 94, 4342-4347.
28. Meccia E, Bottero L, Felicetti F, Peschle C, Colombo MP and Carè A. (2003). Biochem. Biophys. Acta, 1626, 1-9.
29. Niu J, Dorahy DJ, Gu X, Scott RJ, Draganic B, Ahmed N and Agrez MV. (2002). Int. J. Cancer, 99, 529-537.
30. Nomura N, Miyajima N, Sazuka T, Tanaka A, Kawarabayasi Y, Sato S, Nagase T, Seki N, Ishikawa K and Tabata S. (1994). DNA Res., 1, 27-35.
31. Ohashi K, Mizuno K, Kuma K, Miyata T and Nakamura T. (1994). Oncogene, 9, 699-705.
32. Parrado A, Noguera ME, Delmer A, McKenna S, Davies J, Le Gall I, Bentley P, Whittaker JA, Sigaux F, Chomienne C and Padua RA. (2000). Hematol. J., 1, 15-27.
33. Pati D, Zhang N and Plon SE. (2002). Mol. Cell. Biol., 22, 8267-8277.
34. Reid A, Gould A, Brand N, Cook M, Strutt P, Li J, Licht J, Waxman S, Krumlauf R and Zelent A. (1995). Blood, 86, 4544-4552.
35. Satyamoorthy K and Herlyn M. (2002). Cancer Biol. Ther., 1, 14-17.
36. Seftor RE. (1998). Am. J. Pathol., 153, 1347-1351.
37. Sturm RA, Satyamoorthy K, Meier F, Gardiner BB, Smit DJ, Vaidya B and Herlyn M. (2002). Cancer Res., 62, 226-232.
38. Van Belle PA, Elenitsas R, Satyamoorthy K, Wolfe JT, Guerry 4th D, Schuchter L, Van Belle TJ, Albelda S, Tahin P, Herlyn M and Elder DE. (1999). Hum. Pathol., 30, 562-567.
39. van den Oord JJ, Paemen L, Opdenakker G and de Wolf-Peeters C. (1997). Am. J. Pathol., 151, 665-670.
40. Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxman S, Nason-Burchenal K, Dmitrovsky E, Zelent A and Licht JD. (1999). Oncogene, 18, 925-934.